1. Kimryn Rathmell W, Bryan R, Peter, et al. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline. J Clin Oncol. 2022;40:2957–2995. Accessed June 12, 2022. Available at: www.asco.org/genitourinary-cancer-guidelines.
2. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015
3. Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial;Choueiri;Lancet Oncol,2016
4. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial;Motzer;Lancet Oncol,2015
5. Nivolumab plus Ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N Engl J Med,2018